| View |
|
DRP-10077-02
|
Rosuvastatin (as calcium)
|
Rosunis
|
20 mg
|
Tablet
|
Antihyperlipidemic
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
04 October 2023
|
06 October 2025
|
| View |
|
DRP-1012-04
|
Tobramycin
|
Unbranded
|
3 mg / mL (0.3 % w/v)
|
Ophthalmic Solution
|
Antibacterial (Aminoglycosides)
|
Ashford Pharmaceutical Laboratories, Inc.
|
Philippines
|
Renewal
|
20 August 2024
|
08 March 2030
|
| View |
|
DRP-10199-10
|
Trimetazidine Hydrochloride
|
Trimelife
|
35 mg
|
Modified Release Tablet
|
Anti-angina
|
Zim Laboratories Limited
|
India
|
CLIDP Conversion
|
08 October 2023
|
04 August 2026
|
| View |
|
DRP-10199-11
|
Trimetazidine Hydrochloride
|
Retazidine
|
35 mg
|
Modified-Release Tablet
|
Anti-Angina
|
Zim Laboratories Limited
|
India
|
CLIDP Conversion
|
11 October 2023
|
04 August 2026
|
| View |
|
DRP-10246-06
|
Ceftriaxone (as sodium)
|
Triascef
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Third-Generation Cephalosporin)
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
08 October 2023
|
01 October 2026
|
| View |
|
DRP-10282-01
|
Ascorbic Acid + Cholecalciferol (Vitamin D3) + Zinc
|
Immuni-3
|
500 mg (equivalent to 562.43 mg Sodium Ascorbate)/1,000 IU/15 mg (equivalent to 105 mg Zinc Gluconate)
|
Capsule
|
Vitamins/Mineral
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
CLIDP Conversion
|
06 October 2023
|
03 September 2026
|
| View |
|
DRP-10329-01
|
Miconazole
|
Hypharin
|
20 mg/g (2% w/w)
|
Oral Gel
|
Antifungal (Imidazole Derivative)
|
S Kant Healthcare Limited
|
India
|
CLIDP Conversion
|
04 October 2023
|
10 September 2026
|
| View |
|
DRP-10557-03
|
Meropenem (as trihydrate)
|
Meropdica
|
1 g
|
Powder for Injection (I.V.)
|
Antibacterial (Carbapenem)
|
Mepromax Lifesciences Pvt. Ltd
|
India
|
Automatic Renewal
|
22 March 2024
|
15 December 2029
|
| View |
|
DRP-10667-01
|
Losartan Potassium
|
Loswind
|
50 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Sapphire Lifesciences Pvt. Ltd.
Plot No. 43, 44 & 45, Palghar Tal
|
India
|
CLIDP Conversion
|
10 October 2023
|
03 November 2026
|
| View |
|
DRP-10697-03
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Tazodec
|
4 g / 500 mg
|
Powder for Injection for I.V. Infusion
|
Antibacterial (Penicillin / Beta-lactamase Inhibitor)
|
Kilitch Drugs (India) Ltd
|
India
|
CLIDP Conversion
|
26 September 2023
|
10 November 2026
|
| View |
|
DRP-10728-01
|
Salbutamol (as sulfate)
|
Loravent
|
1 mg / mL
|
Nebulizing Solution
|
Anti-Asthma
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
11 September 2023
|
29 January 2025
|
| View |
|
DRP-10830-03
|
Ketoanalogues + Essential Amino Acids
|
Renowind
|
|
Film-Coated Tablet
|
Renal Nutrition Therapy
|
Sapphire Lifesciences Pvt. Ltd
|
India
|
CLIDP Conversion
|
26 September 2023
|
03 December 2026
|
| View |
|
DRP-10868-15
|
Ascorbic Acid + Zinc
|
Ascorbic Acid + Zinc
|
533.40mg (equivalent to 600mg Sodium Ascorbate) + 10mg ( equivalent to 27.45mg Zinc Sulfate)
|
Capsule
|
Vitamin & Mineral
|
Eurasia Research Pharma Corporation
|
Philippines
|
CLIDP Conversion
|
25 September 2023
|
30 October 2025
|
| View |
|
DRP-10868-16
|
Ascorbic Acid + Zinc
|
Peter Cee
|
533.40mg ( equivalent to 600mg Sodium Ascorbate)+ 10mg ( equivalent to 27.45mg Zinc Sulfate)
|
Capsule
|
Vitamin & Mineral
|
Eurasia Research Pharma Corporation
|
Philippines
|
CLIDP Conversion
|
10 October 2023
|
30 October 2025
|
| View |
|
DRP-10892-04
|
Zoledronic Acid (as monohydrate)
|
Zenroniq
|
800 mcg / mL (4 mg / 5 mL)
|
Concentrated Solution for Injection (IV Infusion)
|
Bisphosphonate
|
Aroma Ilac San. Ltd. Sti
|
Turkey
|
CLIDP Conversion
|
11 September 2023
|
14 December 2026
|
| View |
|
DRP-10900-03
|
Levetiracetam
|
Leptam
|
100 mg/mL (500mg/5mL)
|
Concentrated Solution for Injection (IV Infusion)
|
Antiepileptic
|
Aroma Ilac San. Ltd. Sti
|
Turkey
|
CLIDP Conversion
|
11 October 2023
|
14 December 2026
|
| View |
|
DRP-1092-11
|
Co-Amoxiclav
|
Coamoximed
|
312.5 mg (equivalent to 250 mg Amoxicillin + 62.5 mg Clavulanic Acid) per 5 mL
|
Powder for Suspension
|
Antibacterial (Penicillin + Beta-lactamase Inhibitor)
|
Indchemie Health Specialities Private Limited
|
India
|
CLIDP Conversion
|
12 October 2023
|
14 October 2028
|
| View |
|
DRP-1093-07
|
Co-Amoxiclav
|
Coamoxivet
|
156.25 mg per 5 mL
|
Powder for Suspension
|
Antibacterial (Penicillin)
|
Indchemie Health Specialities Private Limited
|
India
|
CLIDP Conversion
|
15 September 2023
|
14 October 2028
|
| View |
|
DRP-10962-02
|
Etoricoxib
|
Etoricass-120
|
120 mg
|
Film-Coated Tablet
|
Non-Steroidal Anti-Inflammatory Drug (Selective COX-2 Inhibitor)
|
Acme Formulation Pvt. Ltd.
|
India
|
CLIDP Conversion
|
11 September 2023
|
23 December 2026
|
| View |
|
DRP-10970-01
|
Ipratropium (as bromide) + Salbutamol (as sulfate)
|
Broncovent Plus
|
200 mcg / 1 mg per mL (500 mcg / 2.5 mg per 2.5 mL)
|
Solution for Inhalation
|
Bronchodilator
|
Althea Pharma Pvt. Ltd
|
India
|
CLIDP Conversion
|
01 October 2023
|
29 December 2026
|